Resources

Research

• Short Summaries for Consumers

Policy

Policy work of the Council and other organizations aimed at improving aspirin use

Other Resources by Type

Fact Sheets

• Council on Aspirin for Health and Prevention (2-page PDF)
  An overview of who is involved in the council as well as its goals and objectives.
• Aspirin’s Evolution: Folk Remedy to Wonder Drug (2-page PDF)
  The story behind aspirin, a drug that costs pennies and can be bought in any grocery,drug or convenience store around the world.
• Men & Women: Protecting Our Hearts & Brains (2-page PDF)
  This fact sheet explains how aspirin benefits and affects each gender differently. It offers information on how to determine whether taking aspirin is a smart move for you.
• Experts Say Aspirin Is Lifesaving (3-page PDF)
  This fact sheet explains who the experts are, and a series of questions you can ask yourself to decide if aspirin is right for you.
• Aspirin and Primary Prevention: Benefits & Harms (3-page PDF)
  This fact sheet for providers helps outline determining if aspirin is right for patients with a decision tree and a table of outcomes.
• Should I Prescribe Aspirin for Primary Prevention in My Patients? (2-page PDF)
  If more healthy adults took daily low-dose aspirin, the number of strokes and heart attacks would be greatly reduced. This fact sheet helps providers understand how to determine if aspirin is right for their patients complete with guidance from the USPSTF.
• Aspirin’s Potential to Prevent Some Cancers (2-page PDF)
  This fact sheet for consumers outlines the benefits of aspirin for preventing some cancers.
• Cancer Prevention: Another Potential Benefit of Low-Dose Aspirin (4-page PDF)
  This fact sheet for providers outlines the benefits of aspirin for preventing some cancers.

Calculators

• Coronary Heart Disease Risk Calculator
• Stroke Calculator
• Is Aspirin Right for Me? Questionnaire

Case Study

• Case Study: Minnesota’s “Ask About Aspirin” Initiative

Webinar Presentation

• ACPM Aspirin and Disease Prevention: A Clinical Perspective (60:02, Archived Webinar)
  This program addressing the appropriate use of aspirin for the prevention of vascular diseases and cancer included 3 speakers on 3 topics. Craig Williams, PharmD, BCPS, FNLA, Oregon Health and Science University spoke about Aspirin and Secondary Prevention. Randall Stafford, MD, PhD, FACPM, Stanford University presented on Aspirin and Primary Prevention. Andrew Chan, MD, MPH, Harvard Medical School presented Aspirin and Cancer. Presented December 3, 2014.

Advertisements

• Ad 1: “A simple aspirincould prevent this” (PDF)
• Ad 2: “Want to stay healthy as you age?” (PDF)

Videos

• Why Consider Aspirin for Cancer Prevention? (5:10, Vimeo)
  A presentation from Andrew T. Chan, MD, MPH, Associate Professor, Department of Medicine, Harvard Medical School, 2013
• Who Should Take Aspirin? Finding the Right Balance (6:54, Vimeo)
  A Question and Answer session with Randall S. Stafford, MD, PHD, Professor of Medicine, Stanford Prevention Research Center, Stanford University
• What Is the Aspirin Project? (1:21, YouTube)
  An overview of information available on the Aspirin Project website (no audio)
• Dr. David Agus on Why Aspirin Is the “Real Health Reform” (CBS This Morning, 2016)
  Includes article in text.
• Aspirin Advocate vs. Skeptic: Any Common Ground? (15:15, requires Flash Player)
  Paul Ridker, a cardiologist at the Brigham and Women's Hospital in Boston and the Harvard Medical School, and John Cleland from the Imperial College and the Royal Brompton Hospital in London discuss aspirin. They divide the “aspirin controversy” into: unstable angina and acute coronary ischemia; secondary prevention; and primary prevention. Transcript also available.
• Cardiology Conundrum: Aspirin for Primary Prevention (9:20, requires Flash Player)
  Sharon L. Mulvagh, MD, director of the Women's Heart Clinic at Mayo Clinic and Dr. Francisco Lopez, director of preventive cardiology at Mayo Clinic discussaspirin and primary prevention and how “FDA Shuts the Door on Aspirin in Primary Prevention.” Transcript also available.
• Continue Aspirin in Endoscopy Patients? A Resounding “Yes” (7:09, requires Flash Player)
  Dr. David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia hosts GI Common Concerns—Computer Consult and commentates on “Reconsidering Aspirin and Endoscopy.” Transcript also available.

Slide Deck

• Council on Aspirin for Health and Prevention: A Retrospective (43-page PDF)
  From the Aspirin Task Force to the Aspirin Project - History and Accomplishments from 2006 to 2016

A References page is available on this website.